Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries

BackgroundIrritable bowel syndrome with predominant constipation (IBS-C) is a complex disorder with gastrointestinal and nervous system components. The study aim was to assess the economic burden of moderate to severe IBS-C in six European countries (France, Germany, Italy, Spain, Sweden and the UK)...

Descripción completa

Detalles Bibliográficos
Autores: Tack, J; Stanghellini, V; Mearin, F; Yiannakou, Y; Layer, P; Coffin, B; Simren, M; Mackinnon, J; Wiseman, G; Marciniak, A; Bouchoucha; Ducrotte; Macaigne; Mion; Schneider; Le Sidanier; Tardy; Zerbib; Andresen; Bischoff; Jander; Jung; Krammer; Langhorst; Omankowsky; Schiefke; Steuer; Van der Voort; Von Arnim; Annese; Cuomo; De Angelis; Di Mario; Di Stefano; Ferrini; Gasbarrini; Giaccobe; Marchi; Marzio; Repici; Savarino; Angos; Berdier; Brotons; Caballero-Plasencia; Clave; Fort; Garcia; Gomez; Martinez; Perello; Rey; Sanchez-Antolin; Serra; Tantina; Toran; Ekesbo; Hellstrom; Kjellstrom; Lindberg; Walter; Arebi; Bridger; Butt; Emmanuel; Eugenicos; Kaushik; Millar; Sanders; Whorwell
Tipo de documento: Artículo
Estado:Published version
Fecha de publicación:2019
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p13821
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13821
Nivel de acceso:Acceso abierto
Palabra clave:IBS
IBS-C
Economic analysis
Healthcare resource utilisation
Europe
_version_ 1878734913063092224
author Tack, J
author2 Stanghellini, V
Mearin, F
Yiannakou, Y
Layer, P
Coffin, B
Simren, M
Mackinnon, J
Wiseman, G
Marciniak, A
Bouchoucha
Ducrotte
Macaigne
Mion
Schneider
Le Sidanier
Tardy
Zerbib
Andresen
Bischoff
Jander
Jung
Krammer
Langhorst
Omankowsky
Schiefke
Steuer
Van der Voort
Von Arnim
Annese
Cuomo
De Angelis
Di Mario
Di Stefano
Ferrini
Gasbarrini
Giaccobe
Marchi
Marzio
Repici
Savarino
Angos
Berdier
Brotons
Caballero-Plasencia
Clave
Fort
Garcia
Gomez
Martinez
Perello
Rey
Sanchez-Antolin
Serra
Tantina
Toran
Ekesbo
Hellstrom
Kjellstrom
Lindberg
Walter
Arebi
Bridger
Butt
Emmanuel
Eugenicos
Kaushik
Millar
Sanders
Whorwell
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_browse Andresen
Angos
Annese
Arebi
Berdier
Bischoff
Bouchoucha
Bridger
Brotons
Butt
Caballero-Plasencia
Clave
Coffin, B
Cuomo
De Angelis
Di Mario
Di Stefano
Ducrotte
Ekesbo
Emmanuel
Eugenicos
Ferrini
Fort
Garcia
Gasbarrini
Giaccobe
Gomez
Hellstrom
Jander
Jung
Kaushik
Kjellstrom
Krammer
Langhorst
Layer, P
Le Sidanier
Lindberg
Macaigne
Mackinnon, J
Marchi
Marciniak, A
Martinez
Marzio
Mearin, F
Millar
Mion
Omankowsky
Perello
Repici
Rey
Sanchez-Antolin
Sanders
Savarino
Schiefke
Schneider
Serra
Simren, M
Stanghellini, V
Steuer
Tack, J
Tantina
Tardy
Toran
Van der Voort
Von Arnim
Walter
Whorwell
Wiseman, G
Yiannakou, Y
Zerbib
author_facet Tack, J
Stanghellini, V
Mearin, F
Yiannakou, Y
Layer, P
Coffin, B
Simren, M
Mackinnon, J
Wiseman, G
Marciniak, A
Bouchoucha
Ducrotte
Macaigne
Mion
Schneider
Le Sidanier
Tardy
Zerbib
Andresen
Bischoff
Jander
Jung
Krammer
Langhorst
Omankowsky
Schiefke
Steuer
Van der Voort
Von Arnim
Annese
Cuomo
De Angelis
Di Mario
Di Stefano
Ferrini
Gasbarrini
Giaccobe
Marchi
Marzio
Repici
Savarino
Angos
Berdier
Brotons
Caballero-Plasencia
Clave
Fort
Garcia
Gomez
Martinez
Perello
Rey
Sanchez-Antolin
Serra
Tantina
Toran
Ekesbo
Hellstrom
Kjellstrom
Lindberg
Walter
Arebi
Bridger
Butt
Emmanuel
Eugenicos
Kaushik
Millar
Sanders
Whorwell
author_role author
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
description BackgroundIrritable bowel syndrome with predominant constipation (IBS-C) is a complex disorder with gastrointestinal and nervous system components. The study aim was to assess the economic burden of moderate to severe IBS-C in six European countries (France, Germany, Italy, Spain, Sweden and the UK).MethodsAn observational, one year retrospective-prospective (6months each) study of patients diagnosed in the last five years with IBS-C (Rome III criteria) and moderate to severe disease at inclusion (IBS Symptom Severity Scale score175). The primary objective was to assess the direct cost to European healthcare systems.ResultsFive hundred twenty-five patients were included, 60% (range: 43.1-78.8%) suffered from severe IBS-C. During follow-up 11.1-24.0% of patients had a hospitalisation/emergency room (ER) visit, median stay range: 1.5-12.0days and 41.1-90.4% took prescription drugs for IBS-C. 21.4-50.8% of employed patients took sick leave (mean: 11.6-64.1days). The mean annual direct cost to the healthcare systems was Euro937.1- Euro2108.0. The total direct cost (combined costs to healthcare systems and patient) for IBS-C was Euro1421.7-Euro2487.1.ConclusionsIBS-C is not a life-threatening condition; however, it has large impact on healthcare systems and society. Direct and indirect costs for moderate to severe IBS-C were high with the largest direct cost driver being hospitalisations/ER visits.
eu_rights_str_mv openAccess
format article
id ES_724f72d4e76dbd519aaec7a152a1fa05
institution Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p13821
publishDate 2019
publishDateSort 2019
publisher BMC
publisherStr BMC
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
spelling Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries Tack, J Stanghellini, V Mearin, F Yiannakou, Y Layer, P Coffin, B Simren, M Mackinnon, J Wiseman, G Marciniak, A Bouchoucha Ducrotte Macaigne Mion Schneider Le Sidanier Tardy Zerbib Andresen Bischoff Jander Jung Krammer Langhorst Omankowsky Schiefke Steuer Van der Voort Von Arnim Annese Cuomo De Angelis Di Mario Di Stefano Ferrini Gasbarrini Giaccobe Marchi Marzio Repici Savarino Angos Berdier Brotons Caballero-Plasencia Clave Fort Garcia Gomez Martinez Perello Rey Sanchez-Antolin Serra Tantina Toran Ekesbo Hellstrom Kjellstrom Lindberg Walter Arebi Bridger Butt Emmanuel Eugenicos Kaushik Millar Sanders Whorwell IBS IBS-C Economic analysis Healthcare resource utilisation Europe BackgroundIrritable bowel syndrome with predominant constipation (IBS-C) is a complex disorder with gastrointestinal and nervous system components. The study aim was to assess the economic burden of moderate to severe IBS-C in six European countries (France, Germany, Italy, Spain, Sweden and the UK).MethodsAn observational, one year retrospective-prospective (6months each) study of patients diagnosed in the last five years with IBS-C (Rome III criteria) and moderate to severe disease at inclusion (IBS Symptom Severity Scale score175). The primary objective was to assess the direct cost to European healthcare systems.ResultsFive hundred twenty-five patients were included, 60% (range: 43.1-78.8%) suffered from severe IBS-C. During follow-up 11.1-24.0% of patients had a hospitalisation/emergency room (ER) visit, median stay range: 1.5-12.0days and 41.1-90.4% took prescription drugs for IBS-C. 21.4-50.8% of employed patients took sick leave (mean: 11.6-64.1days). The mean annual direct cost to the healthcare systems was Euro937.1- Euro2108.0. The total direct cost (combined costs to healthcare systems and patient) for IBS-C was Euro1421.7-Euro2487.1.ConclusionsIBS-C is not a life-threatening condition; however, it has large impact on healthcare systems and society. Direct and indirect costs for moderate to severe IBS-C were high with the largest direct cost driver being hospitalisations/ER visits. BMC https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13821
spellingShingle Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
Tack, J
IBS
IBS-C
Economic analysis
Healthcare resource utilisation
Europe
status_str publishedVersion
title Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
title_full Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
title_fullStr Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
title_full_unstemmed Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
title_short Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
title_sort Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
topic IBS
IBS-C
Economic analysis
Healthcare resource utilisation
Europe
topic_facet IBS
IBS-C
Economic analysis
Healthcare resource utilisation
Europe
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13821